hotspot
Previous article:
The cancer drug shortage isn’t new — and neither are the solutions
Next article: Illumina slashes 2023 revenue projections yet again
Next article: Illumina slashes 2023 revenue projections yet again
hotspot
focus
-
Address the ethical violations that led to 'Three Identical Strangers'
2025-08-31 20:48 -
Surge in Apellis stock fueled by confidence in safety of its eye drug
2025-08-31 20:10 -
Sudafed saga points to U.S. issues with evaluating older drugs
2025-08-31 19:41 -
BMS, looking to build heart drug business, turns to AI for diagnosis
2025-08-31 19:32 -
Judge sides with young activists in first
2025-08-31 19:13 -
Mindstrong's demise and the future of mental health care
2025-08-31 18:23